{"id":"NCT01763645","sponsor":"Biocad","briefTitle":"A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer","officialTitle":"International Multicenter Randomized Double Blind Phase III Trial Comparing Safety and Efficacy of BCD-021 (CJSC BIOCAD, Russia) and Paclitaxel + Carboplatin to AvastinÂ® (F. Hoffmann-La Roche Ltd, Switzerland) and Paclitaxel + Carboplatin in Inoperable or Advanced Non-squamous Non-small-cell Lung Cancer (NSCLC) Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-10","primaryCompletion":"2014-11","completion":"2014-11","firstPosted":"2013-01-09","resultsPosted":"2016-10-24","lastUpdate":"2024-01-11"},"enrollment":353,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Non-small Cell Lung Cancer"],"interventions":[{"type":"DRUG","name":"Bevacizumab","otherNames":["Avastin","BCD-021"]},{"type":"DRUG","name":"Paclitaxel","otherNames":["Taxacad"]},{"type":"DRUG","name":"Carboplatin","otherNames":[]}],"arms":[{"label":"BCD-021 (CISC BIOCAD)","type":"EXPERIMENTAL"},{"label":"Avastin (F. Hoffmann-La Roche Ltd)","type":"ACTIVE_COMPARATOR"}],"summary":"BCD-021-02 is a double-blind randomized clinical trial comparing efficacy of BCD-021 (INN: bevacizumab) and paclitaxel + carboplatin to Avastin and paclitaxel + carboplatin in inoperable or advanced non-squamous NSCLC patients with pharmacokinetics substudy. The purpose of the study is to demonstrate the non-inferiority of efficacy and safety of BCD-021 compared to Avastin. Also study includes pharmacokinetics assessment.","primaryOutcome":{"measure":"Overall Response Rate","timeFrame":"Day 127","effectByArm":[{"arm":"BCD-021 (CISC BIOCAD)","deltaMin":34.63,"sd":null},{"arm":"Avastin (F. Hoffmann-La Roche Ltd)","deltaMin":33.82,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":26},"locations":{"siteCount":44,"countries":["Belarus","India","Russia","Ukraine"]},"refs":{"pmids":["35105329"],"seeAlso":["https://doi.org/10.1186/s12885-022-09243-7"]},"adverseEventsSummary":{"seriousAny":{"events":36,"n":206},"commonTop":["Anaemia","Thrombocytopenia","Neutropenia","Leukopenia","Alopecia"]}}